beta
ACIU
AC Immune SA
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.
Market Cap: 770 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.acimmune.com
Shares Outstanding: 56.9 Million
Float: 56.9 Million
Dividend: 0.0 (0.0%)
Beta: 1.70028
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 1.76 Million
Ethical Flags
Longest drawdown: 766 trading days
From: 2016-09-28 To: 2019-10-11
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|